World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 21 June 2021
Main ID:  ACTRN12616000592448
Date of registration: 06/05/2016
Prospective Registration: No
Primary sponsor: Croix Rouge Francaise
Public title: Developmental and sequenced 1 to 1 educational intervention in children with autism spectrum disorder (ASD): a randomized controlled trial.
Scientific title: Developmental and sequenced one to one educational intervention (DS1-EI) for autism spectrum disorder: a randomized single-blind controlled trial.
Date of first enrolment: 13/05/2013
Target sample size: 70
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12616000592448.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
France
Contacts
Name: Mrs Delphine Le Molgat   
Address:  Croix Rouge Francaise 98 rue Didot 75014, Paris, France France
Telephone: +331 44 43 35 71
Email: Delphine.LeMolgat@croix-rouge.fr
Affiliation: 
Name: Prof David Cohen   
Address:  Department of Child and Adolescent Psychiatry GH Pitie-Salpetriere 47 bd de l'Hopital 75013, Paris, France France
Telephone: +33142162351
Email: david.cohen@aphp.fr
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria :
- a current diagnosis of ASD confirmed by clinical assessment and the Autism Diagnostic Interview-Revised;
- a developmental quotient less than or equal to 24 months;
- no fluent oral language
- aged between 5 to 9 years.
- Controls are matched for sex, age, IQ, study sites before randomization

Exclusion criteria: Exclusion criteria :
- parents’ refusal to participate;
- family project to change institution in the short term whatever the reason;
- patient’s agitation, hyperactivity or behavioral problems that would challenge presence in classroom.


Age minimum: 5 Years
Age maximum: 9 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Mental Health - Autistic spectrum disorders
Autism Spectrum Disorder ;Intellectual disability;
Autism Spectrum Disorder
Intellectual disability
Intervention(s)
Based on what was learned from evidence-based studies, we have developed a novel model named “Developmental and Sequenced one-to-one educational Intervention” (DS1-EI) to deliver 5-9 years children with co-occurring ASD and ID a treatment protocol adapted to school implementation. The treatment protocol was adapted for school implementation by designing it using an educational agenda. The intervention is based on intensity, regular assessments, updating objectives, encouraging spontaneous communication, promoting skills through play with peers, supporting positive behaviours rather than tackling challenging behaviors, providing supervision, capitalizing on teachers’ unique skills, and providing developmental and sequenced learning.

More specifficaly:
(1) Participants randomized in the specific experimental protocol (DS1-EI group) receive 4 mornings per week (each session=2h30) of DS1-EI, while the rest of the week they continue to receive the usual protocol of each site. Given the school holiday calendar in France, participants will receive a maximum of 48 sessions by trimester and 150 sessions per year for a 3-year duration.
(2) The setting is implemented in small classroom with 4 pupils and an adapted environment is proposed. Each child is offered a desk, two chairs (one for the child, one for the adult working with the child), a screen where pictures of the child’s schedule and activities are provided, and a locker with his picture. In contrast to TEACCH (Treatment and Education of Autistic and related Communication handicapped CHildren), The child is sitting with his back close to the wall where the screen stands. The setting includes also (i) a large table for mid-session group collation; (ii) a place offering benches and carpets where to group parti
Primary Outcome(s)
Change in the Psycho-educational profile-3 (PEP-3) score[Baseline (T0), T18 and T36 months post intervention completion]
Secondary Outcome(s)
Change in Children Autism Rating scale (CARS) score[Baseline (T0), T18 and T36 months post intervention completion]
Change in cognitive functioning, assessed using Kaufman Neuropsychological testing (K-ABC) scores[Baseline (T0), T18 and T36 months post intervention completion]
Change in School assessment scores.
The school assessment score follows the curriculum that was adapted from the French program for nursery and primary schools and handiscol principles (http://eduscol.education.fr). It lists a series of abilities that are checked and define as acquired (2 points), being aquired (1 point) and not aquired (0 point).
Regarding academic/educational objectives, they are grouped in four domains: mathematics, language and communication; intermodality and autonomy leading to four scores that are the sum of all the points generated by the specific skills belonging to the corresponding domain.[Baseline (T0), T12, T24 and T36 months post intervention completion]
Change in Clinical Global Impression (CGI) severity and improvement scores based on clinician's assessment[Baseline (T0), T12, T18, T24 and T36 months post intervention completion]
Change in general functioning assessed using the Child-Global Assessment Functioning (C-GAS) score[Baseline (T0), T12, T18, T24 and T36 months post intervention completion]
Change in Vineland II Communication, Adaptation, Socialization and Daily living skills
scores[Baseline (T0), T12, T24 and T36 months post intervention completion]
Secondary ID(s)
ANSM No. 130282B-31
Source(s) of Monetary Support
Fondation Bettencourt-Schueller
Fondation EDF
Croix Rouge Francaise
Caisse Nationale de Solidarite pour l’Autonomie (CNSA)
Secondary Sponsor(s)
Programme de Recherches et d'Etudes sur l'Autisme
Ethics review
Status: Approved
Approval date: 07/05/2013
Contact:
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history